In Vitro Diagnostics Market, By Product & Services (Reagents, Instruments, and Services), By Technology (Hematology, Immunoassay, Molecular Diagnostics, Microbiology, and Others), By Application (Oncology, Diabetes, Cardiology, Infectious Disease, and Others), By End-Users (Hospital Laboratories, Point of Care, Home Care, Clinical Laboratories, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI517323 | Publish Date: February 2024 | No. of Pages: 170

In Vitro Diagnostics Market Overview

In Vitro DiagnosticsMarket was valued at US$ 125.8 Billion in 2024 and is projected to grow at a CAGR of 3.60% to reach US$ 179.6 Billion by 2034.

[PDF] IVD (In-Vitro Diagnostics) tests are used in detecting infections, disease and condition of patients, where tests are typically conducted in smaller equipment or test tubes in laboratories, home or other healthcare centers. HIV tests, blood type identification, cancer screening are some examples of IVD products.

In Vitro Diagnostics Market Dynamics

Growing prevalence of diseases and demand for IVD products to fuel market growth

Growing prevalence of diseases and demand for IVD products has become major contribution in market growth. As the diseases increase, demand for IVD medical devices continues to grow. Growing prevalence of cancer diseases and infectious diseases has given rise in IVD technologies such as molecular diagnostics, immunoassay, hematology, microbiology which in turn, facilitate the demand for In Vitro Diagnostics. Further, high level of accuracy, high sensitivity, inherent specificity and rising prevalence of advanced diagnostic immunoassay formats has driven the demand for In Vitro Diagnostics market growth. Furthermore, technological innovation and huge spending on research and development activities is expected to foster the demand for In Vitro Diagnostics market growth in coming years.

For instance, in 2019, according to CDC (Centers for Disease Control and Prevention), around 1,752,735 new cancer cases were reported and 599,589 people were died of cancer in United States.

Restrains:

However, decline and additional budgetary concerns among healthcare system and unfavorable reimbursement scenario has hampered the demand for In Vitro Diagnostics Market growth.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

In Vitro Diagnostics Market Segmentation

In Vitro Diagnostics Market Segmentation:

In Vitro Diagnostics Market is segmented based on Products & Services, Technology, Application, End-Users and Region.

Product & Services Insight

On the basis of Products & Services, In Vitro Diagnostics Market is segmented into Reagents, Instruments, and Services.

Technology Insight

On the basis of Technology, In Vitro Diagnostics Market is segmented into Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Clinical Chemistry, Coagulation, and Others.

Application Insight

On the basis of Application, In Vitro Diagnostics Market is segmented into Oncology, Diabetes, Cardiology, Infectious Disease, Nephrology, Drug Testing, Autoimmune Disease and Others.

End-Users Insights

On the basis of End-Users, In Vitro Diagnostics Market is segmented into Hospital Laboratories, Point of Care, Home Care, Clinical Laboratories, and Others.

In Vitro Diagnostics Market Regional Insights:

On region the In Vitro Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period due to rising prevalence of chronic disease, growing geriatric population, high disposable income, well-advanced healthcare infrastructure, continuous technological development and adoption of autonomous diagnostic equipment.

Asia Pacific market is estimated to witness a fastest revenue share over the forecast period due to growing population, increased urbanization & prevalence of disease and rising economic status.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2024

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 to 2034

Market Segmentation

By Product & Services – Reagents, Instruments, and Services

By Technology - Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Clinical Chemistry, Coagulation, and Others

By Application - Oncology, Diabetes, Cardiology, Infectious Disease, Nephrology, Drug Testing, Autoimmune Disease and Others

By End-Users - Hospital Laboratories, Point of Care, Home Care, Clinical Laboratories, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032.

Few Other Promising Reports:

In Vitro Diagnostics Market Key Players

In Vitro Diagnostics Market Key Players:

The key players operating the In Vitro Diagnostics Market includes, Abbott, Qiagen, Agilent Technologies Inc., bioMerieux SA, Siemens Healthineers, Sysmex Corp., Danaher Corporation, F-Hoffman-La Roche Ltd., Charles River Laboratories, Becton Dickinson and Company, and Others.

In Vitro Diagnostics Market Company Profile

  1. Company Profiles
  • Abbott
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Qiagen
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Agilent Technologies Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • bioMerieux SA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Siemens Healthineers
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Sysmex Corp.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F-Hoffman-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Charles River Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Becton Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

In Vitro Diagnostics Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product & Services
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End-Users
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. In Vitro Diagnostics Market, By Products & Services, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Reagents
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Instruments
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Services
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. In Vitro Diagnostics Market, By Technology, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Hematology
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Immunoassay
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Molecular Diagnostics
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Microbiology
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Clinical Chemistry
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Coagulation
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. In Vitro Diagnostics Market, By Application, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Oncology
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Diabetes
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Cardiology
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Infectious Disease
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Nephrology
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Drug Testing
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Autoimmune Disease
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. In Vitro Diagnostics Market, By End-Users, Forecast Period up to 10 Years, (US$ Bn)
    • Overview                                      
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
      • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
      • Segment Trends
    • Hospital Laboratories
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Point of Care
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Home Care
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Clinical Laboratories
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  2. In Vitro Diagnostics Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
      • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Product & Services, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Technology, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Product & Services, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Technology, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Product & Services, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Technology, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Product & Services, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Technology, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Product & Services, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End-Users, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East
  1. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis

FAQs

The In Vitro Diagnostics Market is segmented into Products & Services, Technology, Application, End-Users and Region.

By region, the In Vitro Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.

The key players operating the In Vitro Diagnostics Market includes, Abbott, Qiagen, Agilent Technologies Inc., bioMerieux SA, Siemens Healthineers, Sysmex Corp., Danaher Corporation, F-Hoffman-La Roche Ltd., Charles River Laboratories, Becton Dickinson and Company, and Others.

In Vitro DiagnosticsMarket was valued at US$ 125.8 Billion in 2024 and is projected to grow at a CAGR of 3.60% to reach US$ 179.6 Billion by 2034.